More tools:Markets·Screener·Research·Chat

Bicycle Therapeutics plc American Depositary Shares (BCYC) Financial Statements

Bicycle Therapeutics plc American Depositary Shares
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00P0YWQ97
XNAS · usd
4.04▼ 0.14 (-3.33%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close4.18
Day's Range4.17 – 4.28
52-Week Range3.75 – 9.16
Volume261.8K
Avg Volume286.6K
Share Statistics
Shares Outstanding
Employees288
ExchangeXNAS
Listed2019-05-23
Share count as of July 27, 2026
Loading Income Statement…
Key questions about Bicycle Therapeutics plc American Depositary Shares (BCYC)
What is Bicycle Therapeutics plc American Depositary Shares's Market Cap?
Bicycle Therapeutics plc American Depositary Shares's Market Cap is $282.8M, based on as-reported figures from SEC (XBRL) filings.
What is Bicycle Therapeutics plc American Depositary Shares's Enterprise Value?
Bicycle Therapeutics plc American Depositary Shares's Enterprise Value is -$226.5M, based on as-reported figures from SEC (XBRL) filings.
What is Bicycle Therapeutics plc American Depositary Shares's Price / Sales?
Bicycle Therapeutics plc American Depositary Shares's Price / Sales is 4.6×, based on as-reported figures from SEC (XBRL) filings.
What is Bicycle Therapeutics plc American Depositary Shares's EV / Revenue?
Bicycle Therapeutics plc American Depositary Shares's EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Bicycle Therapeutics plc American Depositary Shares's EV / EBITDA?
Bicycle Therapeutics plc American Depositary Shares's EV / EBITDA is 1.1×, based on as-reported figures from SEC (XBRL) filings.
What is Bicycle Therapeutics plc American Depositary Shares's Revenue (TTM)?
Bicycle Therapeutics plc American Depositary Shares's Revenue (TTM) is $61.2M, based on as-reported figures from SEC (XBRL) filings.
What is Bicycle Therapeutics plc American Depositary Shares's Net Income (TTM)?
Bicycle Therapeutics plc American Depositary Shares's Net Income (TTM) is -$190.4M, based on as-reported figures from SEC (XBRL) filings.
What is Bicycle Therapeutics plc American Depositary Shares's EBITDA?
Bicycle Therapeutics plc American Depositary Shares's EBITDA is -$205.0M, based on as-reported figures from SEC (XBRL) filings.
What is Bicycle Therapeutics plc American Depositary Shares's Diluted EPS (TTM)?
Bicycle Therapeutics plc American Depositary Shares's Diluted EPS (TTM) is -2.72, based on as-reported figures from SEC (XBRL) filings.
What is Bicycle Therapeutics plc American Depositary Shares's EBITDA Margin?
Bicycle Therapeutics plc American Depositary Shares's EBITDA Margin is -335.0%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Condensed Consolidated Statements of Operations and Comprehensive Loss
Collaboration revenue—
YoY growth-78.5%—+1193.3%+338.5%
Operating expenses:
Research and development—
General and administrative—
Total operating expenses—
% of revenue8773.9%—151.5%658.6%
Loss from operations—
% of revenue-8673.9%—-51.5%-558.6%
Other income (expense):
Interest and other income—
Interest expense—
Total other income, net—
Net loss before income tax provision—
Net loss
% of revenue-8002.1%—-42.0%-503.7%
Net loss per share, basic (in dollars per share)—
Net loss per share, diluted (in dollars per share)—